Supreme Court Favors Medtronic, Licensees In Patent Case
This article was originally published in The Pink Sheet Daily
Executive Summary
The court found that a patent holder must prove infringement, even when a company licensing a patent is the one filing the lawsuit. The decision favors Medtronic over Boston Scientific in this dispute over cardiac resynchronization therapy patents, and, more broadly, gives more leverage to licensees in patent disputes.